AAAAAA
Results:
1-7
|
Results: 7
Authors:
Satyamoorthy, K
Bogenrieder, T
Herlyn, M
Citation: K. Satyamoorthy et al., No longer a molecular black box - new clues to apoptosis and drug resistance in melanoma, TRENDS MO M, 7(5), 2001, pp. 191-194
Authors:
Bogenrieder, T
Landthaler, M
Stolz, W
Citation: T. Bogenrieder et al., Airborne contact dermatitis due to chloroacetamide in wall paint, CONTACT DER, 45(1), 2001, pp. 55-55
Authors:
Burgdorff, T
Douwes, KE
Bogenrieder, T
Szeimies, RM
Hohenleutner, U
Landthaler, M
Stolz, W
Citation: T. Burgdorff et al., Superior vena cava syndrome: An important differential diagnosis in patients with facial edema, ACT DER-VEN, 81(3), 2001, pp. 205-206
Authors:
Bosserhoff, AK
Hauschild, A
Hein, R
Schadendorf, D
Stockfleth, E
Bogenrieder, T
Landthaler, M
Buettner, R
Stolz, W
Citation: Ak. Bosserhoff et al., Elevated MIA serum levels are of relevance for management of metastasized malignant melanomas: Results of a German multicenter study, J INVES DER, 114(2), 2000, pp. 395-396
Authors:
Lohmann, CP
Kroher, G
Bogenrieder, T
Spiegel, D
Preuner, J
Citation: Cp. Lohmann et al., Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma, LANCET, 353(9161), 1999, pp. 1326-1326
Authors:
Vogt, T
Kroiss, M
McClelland, M
Gruss, C
Becker, B
Bosserhoff, AK
Rumpler, G
Bogenrieder, T
Landthaler, M
Stolz, W
Citation: T. Vogt et al., Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer, LAB INV, 79(12), 1999, pp. 1615-1627
Authors:
Kroiss, MM
Bosserhoff, AK
Vogt, T
Buettner, R
Bogenrieder, T
Landthaler, M
Stolz, W
Citation: Mm. Kroiss et al., Loss of expression or mutations in the p73 tumour suppressor gene are not involved in the pathogenesis of malignant melanomas, MELANOMA RE, 8(6), 1998, pp. 504-509
Risultati:
1-7
|